Diversified Growth Company - Medtech DPM EUR H
LU2304351971
Diversified Growth Company - Medtech DPM EUR H/ LU2304351971 /
NAV30.10.2024 |
Diff.+0,0500 |
Ertragstyp |
Ausrichtung |
Fondsgesellschaft |
79,0600EUR |
+0,06% |
thesaurierend |
Aktien
weltweit
|
NS Partners ▶ |
Investmentstrategie
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
Investmentziel
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
Zusatzinfotext
Dieser Fonds befindet sich in Liquidation.
Stammdaten
Ertragstyp: |
thesaurierend |
Fondskategorie: |
Aktien |
Region: |
weltweit |
Branche: |
Branche Gesundheit/Pharma |
Benchmark: |
MSCI World Health Care Equipment and Supplies (USD) index |
Geschäftsjahresbeginn: |
01.01 |
Letzte Ausschüttung: |
- |
Depotbank: |
UBS Europe SE, Luxembourg Branch |
Ursprungsland: |
Luxemburg |
Vertriebszulassung: |
Schweiz |
Fondsmanager: |
NS Partners SA |
Fondsvolumen: |
25,2 Mio.
USD
|
KESt-Meldefonds: |
- |
Auflagedatum: |
11.02.2022 |
Investmentfokus: |
- |
Konditionen
Ausgabeaufschlag: |
3,00% |
Max. Verwaltungsgebühr: |
1,50% |
Mindestveranlagung: |
- EUR |
Weitere Gebühren: |
0,04% |
Tilgungsgebühr: |
0,00% |
Laufende Kosten (31.12.2019): |
1,90% |
Wesentliche Anlegerinformation: |
Download (Druckversion) |
Fondsgesellschaft
KAG: |
NS Partners |
Adresse: |
11, Boulevard de la Foire, 1528, Luxembourg |
Land: |
Luxemburg |
Internet: |
www.nspgroup.com/
|
Veranlagungen
Aktien |
|
98,40% |
Barmittel und sonstiges Vermögen |
|
1,60% |
Länder
Nordamerika |
|
71,50% |
Schweiz |
|
17,20% |
Europa |
|
9,60% |
Sonstige |
|
1,70% |
Branchen
Gesundheitswesen |
|
98,40% |
Barmittel und sonst. VM |
|
1,60% |